Unresolved questions with the use of linezolid vs vancomycin for nosocomial pneumonia [9]

Chest

Volumn 125, Issue 6, 2004, Pages 2370-2371

  Kalil, Andre C ^a,b   Puumala, Susan E ^a   Stoner, Julie ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; VANCOMYCIN;

BACTERIAL PNEUMONIA; DRUG EFFICACY; FOLLOW UP; HOSPITAL INFECTION; HUMAN; LETTER; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STATISTICAL ANALYSIS; STATISTICAL MODEL; TREATMENT OUTCOME;

EID: 2942699900     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.6.2370     Document Type: Letter

References (1)

1. Wunderink RG, Rello J, Cammarata SK, et al. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 2003; 124:1789-1797